How to Value a Veterinary Specialty Hospital in 2026

Veterinary specialty hospitals — the ones with board-certified surgeons, oncologists, cardiologists, internists, and neurologists — are the crown jewels of veterinary M&A. They're rare, they're hard to build, and buyers pay accordingly. In the last 24 months I've seen platform specialty hospitals trade at 14-18x adjusted EBITDA, with the top tier above 20x when there's real scarcity value in a desirable market.

The buyer universe is narrow but well-capitalized: Ethos Veterinary Health, BluePearl (Mars Petcare), Compassion-First (now part of NVA), MedVet, and a handful of PE-backed regional platforms. If you own a specialty hospital generating $8M+ in revenue with solid margins, all of these names already know who you are.

Why Specialty Commands the Highest Multiples in Veterinary

General practice hospitals trade around 8-12x. Emergency-only hospitals trade 10-16x. Specialty hospitals trade 12-18x — and combined specialty/ER hospitals (what Ethos and BluePearl are really building) can trade above 20x in the right markets.

The multiple premium comes from three structural advantages. Board-certified specialists are genuinely scarce — there are fewer than 400 veterinary oncologists and fewer than 250 veterinary cardiologists in the entire United States. You cannot just hire your way into a new market. Revenue per case is 3-5x higher than general practice — a single radiation oncology course runs $8,000-$14,000, a TPLO surgery runs $5,500-$7,500, and a cardiology workup with echocardiogram is $1,800-$2,500. And the referral relationships are sticky — GPs and ER hospitals refer to specialists they trust, and those relationships survive ownership changes better than any other category in veterinary medicine.

How Buyers Value Specialty Hospitals

Buyers underwrite specialty hospitals service-line by service-line. Each specialty has its own economics, its own scarcity, and its own multiple. A hospital with a full oncology program including linear accelerator (linac) gets valued very differently than one with just surgery and internal medicine.

Here's roughly how buyers mentally segment the services:

• Surgery (DACVS): The workhorse. Typically 30-45% of specialty hospital revenue. High margin, scalable with additional surgeons. Valued at the core specialty multiple.
• Internal medicine (DACVIM): High case volume, moderate transaction values, excellent recurring revenue from chronic disease management.
• Oncology (DACVIM-Oncology): Highest per-case revenue. Radiation oncology with a linac is genuinely rare — maybe 80 sites in the US — and commands a premium multiple of its own.
• Cardiology (DACVIM-Cardiology): Scarce specialists. Lower case volume than IM but high-value workups.
• Neurology: MRI-dependent, high acuity. Adds real depth to a hospital's capabilities.
• Emergency and critical care integrated: Combined specialty/ER hospitals are the most valuable configuration — buyers pay 2-3 turns more for this model than specialty-only.

The Specialist Retention Problem

Board-certified specialists are the asset. Lose two of them post-close and the buyer's investment thesis collapses. Every sophisticated buyer will require 3-5 year employment agreements with meaningful non-competes from your key specialists as a condition of closing. If your specialists won't sign, you don't have a deal.

This is something you need to solve before going to market, not during diligence. The conversation with your specialists usually involves some form of sale proceeds participation — either through equity roll, retention bonuses, or a minority ownership stake they can roll into the new platform. Budget 8-15% of the purchase price for specialist retention mechanics. I've seen deals die in the final week because a cardiologist who was told they'd get $500K of the proceeds found out they were getting $120K.

Compensation structures also get scrutinized. Most specialists earn base plus ProSal (production-based percentage), typically 18-22% of their personal production. Buyers will normalize this if your specialists are underpaid — which adds cost and reduces EBITDA. If your surgeon is doing $2.4M in production and earning $320K total, the buyer will assume they need to pay $450K-$520K to retain them and your pro-forma drops $130K-$200K. Pay your specialists market rates well before you go to market.

Equipment Economics

Specialty hospitals are capital-intensive in a way that general practices aren't. A fully-equipped specialty hospital with surgery, IM, oncology, and cardiology capabilities has $4M-$9M in equipment at replacement cost. Add radiation oncology (a linac) and you're at $7M-$14M. Buyers underwrite this carefully because equipment age directly drives capex requirements.

Key equipment line items buyers focus on:

• MRI: A 1.5T veterinary MRI runs $900K-$1.4M new. Useful life 10-12 years. If yours is from 2013, expect the buyer to model a full replacement in year 2-3.
• CT: $400K-$800K. 8-10 year useful life.
• Linear accelerator (radiation oncology): $2.5M-$4.5M. 12-15 year useful life. Extraordinarily valuable because of scarcity.
• Surgical suites: Multiple OR suites with anesthesia, monitoring, C-arm fluoroscopy — $300K-$600K per suite.
• ICU capacity: Ventilators, continuous monitoring, oxygen cages. $400K-$900K depending on bed count.

The hospitals that get the best multiples have equipment under 5 years old across all core modalities, a documented capex replacement schedule, and service contracts in place with Canon, GE, or Siemens.

Referral Network and Market Position

Specialty hospital revenue is almost entirely referral-driven. Your GP and ER referral base isn't a nice-to-have — it's the entire business. Buyers will ask for your referral reporting and want to see:

• A base of 80-200+ referring hospitals in your catchment area
• No single referring hospital over 8-10% of total case volume
• Balanced referrals across all your service lines (not 70% coming into surgery)
• Active GP outreach and CE programs (lunch & learns, rounds)
• Formal or informal exclusivity with nearby ER-only hospitals

Market position matters enormously. A specialty hospital that's the only game in town within a 90-minute drive has pricing power and volume certainty that a buyer will pay 3-4 extra turns for. A hospital competing head-to-head with an Ethos or BluePearl location 15 minutes away faces margin pressure and gets valued accordingly.

What Destroys Value

Single-specialist dependency. If your oncology program is one DVM and they leave, you lose 100% of oncology revenue overnight. Hospitals with single points of specialist failure trade at a discount of 2-3 turns of EBITDA.

No emergency/critical care coverage. Pure specialty hospitals without ER coverage are harder to sell than integrated specialty/ER hospitals. Buyers see the ER capability as a referral pipeline and case flow stabilizer. If you don't have it, your multiple drops.

Outdated practice management systems. Buyers need to see clean data on case volumes, referral sources, and specialist productivity. Hospitals running on paper or legacy systems lose 6-12 months in diligence and often see purchase prices revised down when the data finally comes out.

Unclear physical plant ownership. Many specialty hospitals operate out of purpose-built buildings the DVM owners developed. Make sure your real estate ownership, mortgage, and lease structure is documented and clean before you go to market.

Preparing for a Specialty Hospital Sale

Start 24-36 months before you want to close. Build specialist redundancy — your highest-volume service lines should have at least two boarded specialists. Lock in employment agreements and align economics. Upgrade aging equipment, especially imaging. Clean up add-backs and get reviewed financials.

Run a structured process with an experienced healthcare M&A advisor. The buyer universe is small and the deals are complex — this is not a market where a generalist broker will get you the best outcome. Expect 6-9 months from launch to close, with diligence alone running 90-120 days. Purchase price is typically paid 70-80% at close with the remainder in a 2-3 year earnout tied to EBITDA retention and specialist stability. See our guide on preparing your business for sale for a broader timeline.

The Bottom Line

Specialty veterinary hospitals are arguably the most valuable asset class in the entire veterinary industry. The multiples reflect genuine scarcity — of specialists, of capital, and of markets — and they aren't going to compress meaningfully anytime soon. If you own a well-run specialty hospital with stable specialist staffing, modern equipment, and a diversified referral base, you're sitting on an asset that will trade in the mid-teens of EBITDA and potentially higher. The prep work is substantial, but the reward is a once-in-a-career exit.